HC
FOLD

Henshaw Capital’s Amicus Therapeutics FOLD Stock Holding History

Henshaw Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,882
Closed -$346K – 196
2025
Q3 		$346K Sell
43,882
-9,073
-17% -$64.6K 0.01% 219
2025
Q2 		$303K Hold
52,955
– – 0.01% 275
2025
Q1 		$432K Hold
52,955
– – 0.02% 245
2024
Q4 		$499K Hold
52,955
– – 0.02% 221
2024
Q3 		$566K Buy
52,955
+4,413
+9% +$48.1K 0.02% 205
2024
Q2 		$482K Buy
48,542
+819
+2% +$8.41K 0.02% 179
2024
Q1 		$562K Hold
47,723
– – 0.03% 160
2023
Q4 		$677K Buy
47,723
+4,743
+11% +$53.9K 0.04% 137
2023
Q3 		$523K Buy
42,980
+15,619
+57% +$201K 0.03% 148
2023
Q2 		$344K Hold
27,361
– – 0.02% 161
2023
Q1 		$303K Hold
27,361
– – 0.02% 176
2022
Q4 		$334K Hold
27,361
– – 0.02% 164
2022
Q3 		$286K Hold
27,361
– – 0.02% 210
2022
Q2 		$294K Hold
27,361
– – 0.02% 223
2022
Q1 		$259K Hold
27,361
– – 0.02% 277
2021
Q4 		$316K Hold
27,361
– – 0.02% 254
2021
Q3 		$261K Hold
27,361
– – 0.02% 281
2021
Q2 		$264K Buy
27,361
+3,406
+14% +$33.2K 0.02% 302
2021
Q1 		$237K Buy
23,955
+10,430
+77% +$161K 0.02% 314
2020
Q4 		$312K Buy
+13,525
New +$277K 0.02% 248

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Henshaw Capital's FOLD Position: Q4 2025 in Review

Henshaw Capital sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 43,882 shares — an estimated $346K sold.

Henshaw Capital first reported a position in FOLD in Q4 2020 and held it in 20 quarters. The position peaked at $677K in Q4 2023. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Henshaw Capital reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Henshaw Capital sold 43,882 Amicus Therapeutics shares in Q4 2025, an estimated $346K.
  • Henshaw Capital first reported a position in Amicus Therapeutics in Q4 2020 and held it in 20 quarters.
  • Henshaw Capital's Amicus Therapeutics position peaked at $677K in Q4 2023.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Henshaw Capital's 13F filing for Q4 2025, filed 28 May 2026.